Cargando…

NI-07 VALIDATION OF MACHINE LEARNING BASED HIGH GRADE GLIOMA MR SEGMENTATION VIA METHIONINE PET

Treatment planning and lesion-follow up are generally conducted by contrast-enhanced MRI in glioma patient care. On the other hand, there are, however, substantial concerns whether MRI actually reflects the extension or activity of this neoplasm, which information should be fundamentally important a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Manabu, Ozaki, Tomohiko, Arita, Hideyuki, Kagawa, Naoki, Kanemura, Yonehiro, Fujimoto, Yasunori, Sakai, Mio, Watanabe, Yoshiyuki, Nakanishi, Katsuyuki, Shimosegawa, Eku, Hatazawa, Jun, Kishima, Haruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213347/ http://dx.doi.org/10.1093/noajnl/vdz039.120

Ejemplares similares

Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via (11)C-methionine positron emission tomography
por: Ozaki, Tomohiko, et al.
Publicado: (2019)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Magnetic Resonance Relaxometry for Tumor Cell Density Imaging for Glioma: An Exploratory Study via (11)C-Methionine PET and Its Validation via Stereotactic Tissue Sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map
por: Yamamoto, Shota, et al.
Publicado: (2022)

Influence of region-of-interest designs on quantitative measurement of multimodal imaging of MR non-enhancing gliomas
por: Takano, Koji, et al.
Publicado: (2018)

T(2)-FLAIR Mismatch Sign Is Caused by Long T(1) and T(2) of IDH-mutant, 1p19q Non-codeleted Astrocytoma
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas
por: Kinoshita, Manabu, et al.
Publicado: (2016)

ACT-07 Clinical Trials of 11C-Methionine PET for brain tumors
por: Yamaguchi, Shigeru, et al.
Publicado: (2020)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases
por: Izutsu, Nobuyuki, et al.
Publicado: (2021)

Enlargement of papillary glioneuronal tumor in an adult after a follow-up period of 10 years: a case report
por: Fujita, Yuya, et al.
Publicado: (2018)

NI-12 The ratio of T1-Weighted to T2-Weighted Signal Intensity and IDH mutation in glioma
por: Sanada, Takahiro, et al.
Publicado: (2021)

SS-2 Current status and future perspective of radiomics in glioma imaging
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Reverse Engineering Glioma Radiomics to Conventional Neuroimaging
por: KINOSHITA, Manabu, et al.
Publicado: (2021)

NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
por: Sanada, Takahiro, et al.
Publicado: (2022)

Correlation of T1- to T2-weighted signal intensity ratio with T1- and T2-relaxation time and IDH mutation status in glioma
por: Sanada, Takahiro, et al.
Publicado: (2022)

NI-2 Use of neurite orientation dispersion and density imaging(NODDI)for early distinction between infiltrating tumor and vasogenic edema in non-enhancing lesions with glioblastoma patients
por: Okita, Yoshiko, et al.
Publicado: (2021)

Determination of brain tumor recurrence using (11)C‐methionine positron emission tomography after radiotherapy
por: Yamaguchi, Shigeru, et al.
Publicado: (2021)

NI-13 PREDICTION OF PROGNOSIS IN NEWLY DIAGNOSED GLIOBLASTOMA USING MACHINE LEARNING-BASED TEXTURE ANALYSIS OF PREOPERATIVE MRI
por: Umehara, Toru, et al.
Publicado: (2019)

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts
por: Umehara, Toru, et al.
Publicado: (2019)

Optimization of [(11)C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV
por: Isohashi, Kayako, et al.
Publicado: (2013)

IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS
por: Kagawa, Naoki, et al.
Publicado: (2019)

CT-Based Attenuation Correction in Brain SPECT/CT Can Improve the Lesion Detectability of Voxel-Based Statistical Analyses
por: Kato, Hiroki, et al.
Publicado: (2016)

Radiosynthesis of (11)C-phenytoin Using a DEGDEE Solvent for Clinical PET Studies
por: Kanai, Yasukazu, et al.
Publicado: (2018)

Increase in extraction of I-123 iomazenil in patients with chronic cerebral ischemia
por: Kato, Hiroki, et al.
Publicado: (2018)

GCT-69. VOLUMETRIC CHANGE BEFORE CHEMORADIOTHERAPY AND INFLUENCE OF DIAGNOSTIC RADIATION EXPOSURE IN INTRACRANIAL GERMINOMAS
por: Kagawa, Naoki, et al.
Publicado: (2020)

Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy
por: Nakagawa, Tomoyoshi, et al.
Publicado: (2022)

IM-7 Identification of novel glioblastoma specific antigen using patient derived tumor cell for CAR-T cell therapy
por: Nakagawa, Tomoyoshi, et al.
Publicado: (2021)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

NI-02 THE ASSOCIATION BETWEEN (11)C-METHIONINE UPTAKE, IDH GENE MUTATION, AND MGMT PROMOTER METHYLATION IN PATIENTS WITH GRADE II AND III GLIOMAS
por: Okita, Yoshiko, et al.
Publicado: (2019)

Quantitative pulmonary blood flow measurement using (15)O-H(2)O PET with and without tissue fraction correction: a comparison study
por: Matsunaga, Keiko, et al.
Publicado: (2017)

Surgical resection of glioblastoma in basal ganglia and utility of exoscope: Technical case reports
por: Kijima, Noriyuki, et al.
Publicado: (2023)

STMO-10 SURGICAL RESECTION FOR PRIMARY MOTOR CORTEX GLIOMA, TWO CASE REPORTS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas?
por: Yamada, Shuhei, et al.
Publicado: (2021)

Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network
por: Fukuma, Ryohei, et al.
Publicado: (2019)

NI-13 The effectiveness and limitation of survival prediction in primary glioblastoma using machine learning-based texture analysis
por: Umehara, Toru, et al.
Publicado: (2020)

Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion
por: Achiha, Takamune, et al.
Publicado: (2020)

MPC-04 MOLECULAR FEATURES AND CLINICAL OUTCOMES OF ELDERLY GLIOBLASTOMA PATIENTS: ANALYSES OF KANSAI NETWORK AND TCGA COHORTS
por: Fukai, Junya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s7bstpslm7hb7amph4lc5ggbr6